4748. Horse Chestnut

Description and references

Deciduous, flowering tree, Aesculus hippocastanum L., Hippocastanaceae, bearing spiny, globular fruit capsules that contain up to 3 reddish brown, inedible seeds. Medicinal portions are the dried leaves and an extract prepared from the seeds. Habit. Balkan peninsula; widely cultivated in Northern hemisphere as a shade tree. Constit. Mixture of triterpene saponins known as escin, q.v. (3-5%); coumarins such as esculetin, fraxin, scopolin; flavonoids incl. astragalin, isoquercetin, rutin, leucocyanidin; tannins, starch, fatty acids; also contains the toxic glycoside, esculin. Comprehensive description: N. Tiffany et al., J. Herb. Pharmacother. 2, 71-85 (2002). Review of constituents and uses: J. Barnes et al., Herbal Medicines (Pharmaceutical Press, London, 2nd Ed., 2002) pp 296-299; A. Y. Leung, S. Foster, Encyclopedia of Common Natural Ingredients, (Wiley-Interscience, Hoboken, 2nd Ed., 2003) pp 304-306; J. Gruenwald et al., PDR for Herbal Medicines (Medical Economics, Montvale, 3rd Ed., 2004) pp 445-448.

Derivative

Dried extract.

Nomenclature

CAS number: 8053-39-2
Horse chestnut seed extract; Aescorin (Steigerwald); Aescusan (Jenapharm); Essaven (Cassella-med); Venalot (Schaper & Brummer); Venoplant (Schwabe); Venopyronum (Abbott); Venostasin (Klinge).

Description and references

Principle constituent is escin which is used to calculate potency. Clinical pharmacokinetics and bioavailability of formulations: D. Bssler et al., Adv. Ther. 20, 295 (2003). Review of clinical trials in chronic venous insufficiency: U. Siebert et al., Int. Angiol. 21, 305-315 (2002).

Caution

Potential symptoms of toxicity following ingestion of leaves, bark, flowers or raw seeds are vomiting, diarrhea, headache, stupor, coma, paralysis (Tiffany).

Use

In shampoos, skin care products, body and hand creams, lotions.

Therapeutic Category

Seed extract in treatment of chronic venous insufficiency.